Scott P Salowe Selected Research

Hypoxia-Inducible Factor-Proline Dioxygenases

12/2016	Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia.
4/2012	1,3,8-Triazaspiro[4.5]decane-2,4-diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott P Salowe Research Topics

Disease

2	Anemia 12/2016 - 04/2012
1	Hypoxia (Hypoxemia) 12/2016
1	Hypercholesterolemia 12/2016
1	Infections 02/2006
1	Anthrax 02/2006

Drug/Important Bio-Agent (IBA)

2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 12/2016 - 04/2012
2	Hypoxia-Inducible Factor-Proline DioxygenasesIBA 12/2016 - 04/2012
1	bis(4- methoxyphenyl)methyl)- 4- hydroxy- 2- (pyridazin- 3- yl)pyrimidine- 5- carboxamideIBA 12/2016
1	LDL CholesterolIBA 12/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2016
1	Pharmaceutical PreparationsIBA 12/2016
1	decaneIBA 04/2012
1	EnzymesIBA 04/2012
1	PyransIBA 02/2006
1	acetamideIBA 02/2006

Therapy/Procedure

1	Therapeutics 02/2006